Group Leader
© CMCB
Group Leader
NameProf. Ezio Bonifacio
Preclinical Stem Cell Therapy/ Diabetes
Send encrypted email via the SecureMail portal (for TUD external users only).
Prof. Ezio Bonifacio is Chair for "preclinical stem cell therapy and diabetes" at the Faculty of Medicine of the TU Dresden.
Education
|
1992 |
PhD in Pathology (University of Western Australia) |
|
1988 |
Bachelor of Applied Science (Curtin University, Western Australia) |
Positions held
| since 2019 | Co-Director, Dresden Genome Center Next Generation Sequencing Competence Center |
|
2016 - 2018 |
Director of the CRTD |
|
since 2007 |
Professor, Center for Regenerative Therapies, Technische Universität Dresden, Germany |
|
2001 - 2007 |
Director, Telethon-JDRF Center for Beta Cell Replacement, San Raffaele Scientific Institute, Milan, Italy |
|
1999 |
von Humboldt fellow, Institute of Diabetes Research, Munich, Germany |
|
1996 - 2007 |
Head of Unit, Immunology of Diabetes, San Raffaele Scientific Institute, Milan, Italy |
|
1993 - 1996 |
Assistente Ricercatore, Department of Medicine, San Raffaele Scientific Institute, Milan, Italy |
|
1991 - 1992 |
Lecturer, Department of Immunology, London Hospital Medical College |
|
1989 - 1991 |
JDF Research Fellow, Department of Immunology, Middlesex Hospital Medical School, London |
|
1987 - 1988 |
Visiting Research Fellow, Department of Immunology, Middlesex Hospital Medical School, London |
|
1983 - 1989 |
Senior Technologist, Department of Clinical Immunology, QEII Med Centre, Western Australia |
|
1981 - 1983 |
Medical Technologist, Department of Clinical Immunology, QEII Med Centre, Western Australia |
|
1979 - 1980 |
Research Assistant, Department of Pathology, University of Western Australia |